P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)

Background: In 30% of patients with brain metastasis (BM), BM are the first clinical manifestation of systemic malignancy, referred to as BM from cancer of unknown primary site (BM-CUPS). The value of (18)F-fluordesoxyglucose positron emission tomography (FDG-PET)/CT in the work-up of BM-CUPS patien...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Wolpert, F., Le Rhun, E., Berghoff, A., Rushing, E., Andratschke, N., Regli, L., Reyns, N., Kaufmann, P., Preusser, M., Weller, M.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
POSTER PRESENTATIONS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464281/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.410
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы